Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Set To Impose New Rules On Key Imported Drug Prices

This article was originally published in PharmAsia News

Executive Summary

The Indian government is nearing completion of a set of standards to use in ensuring the prices charged for critical drugs by multinational drug makers are under control. The government considers some of the prices for imported drugs to treat arthritis, diabetes, cancer, heart disease and obesity too high even if they are covered by the government's price control system. The new standards would allow the government to negotiate for certain drugs based on prices charged in other markets. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070793

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel